Know Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
May 15, 2023 at 04:05 pm
Share
Know Labs, Inc. reported earnings results for the second quarter and six months ended March 31, 2023. For the second quarter, the company reported net loss was USD 4.93 million compared to USD 6.14 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.16 a year ago. Diluted loss per share from continuing operations was USD 0.1 compared to USD 0.16 a year ago.
For the six months, net loss was USD 8.75 million compared to USD 11.5 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.31 a year ago. Diluted loss per share from continuing operations was USD 0.18 compared to USD 0.31 a year ago.
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Companyâs Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Companyâs trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.